Antibiotics for lower respiratory tract infections. Still too frequently prescribed?

Canadian Family Physician

Volumn 50, Issue APR., 2004, Pages 569-575

  McIsaac, Warren J ^a   To, Teresa ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFALEXIN; CEFPROZIL; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; PIVAMPICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD ANALYSIS; BRONCHITIS; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; DIAGNOSTIC TEST; FEMALE; GENERAL PRACTITIONER; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MORAXELLA CATARRHALIS; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROSPECTIVE STUDY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; THORAX RADIOGRAPHY; THROAT CULTURE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHITIS; CANADA; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 1942474666     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
2. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;2788: 901-4.
3. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK. Diagnosis of acute bronchitis in adults a national survey of family physicians. J Fam Pract 1997;45:402-9.
4. MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996;11:557-62.
5. Meza RA, Bridges-Webb C, Sayer GP, Miles DA, Traynor V, Neary S. The Management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990-1991. Aust Fam Physician 1994;23:1550-3.
6. Mainous AG III, Zoorob RJ, Hueston WJ. Current management of acute bronchitis in ambulatory care. The use of antibiotics and bronchodilators. Arch Fam Med 1996;5:79-83.
7. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines. Respir Med 1997;91:427-34.
8. Kawamoto R, Asai Y, Nago N, Masanobu O, Mise J, Igarashi M. A study of clinical features and treatment of acute bronchitis by Japanese primary care physicians. Fam Pract 1998;15:244-51.
9. Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adults with cough. Arch Intern Med 1998;158:1813-8.
10. Gonzales R, Sande M. What will it take to stop physicians from prescibing antibiotics in acute bronchitis? Lancet 1995;345:665-6.
11. Snow V. Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001;134:518-20.
12. Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998;316:906-10.
13. Smucny JJ, Becker LA, Glazier RH, McIsaac W. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998;47(6):453-60.
14. Health canada and the Canadian Infectious Disease Society. Controlling antimicrobial resistance. An integrated action plan for Canadians. Can Commun Dis Rep 1997;23 (Suppl 7):i-iv,1-32.
15. Zhanel GG, Karlowsky JA, Palatnick L, Vercaigne L, Low DE, Hoban DJ. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptoccus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group. Antimicrob Agents Chemother 1999;43:2504-9.
16. Whitney CG, Farley MM, Hadler JH, Lexau C, Reingold A, et al. Increasing prevalence of multi-drug resistant Streptococcus Pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
17. Chen DK, McGeer A, De Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to flouroquinolones in Canada. N Engl J Med 1999;341:233-9.
18. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, De Azavedo JCS, Kibsey P, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002;346:747-50.
19. Zhanel GG, Karlowsky JA, Low DE, Hoban DJ. Antibiotic resistance in respiratory tract isolates of Haemphilus influenziae and Moraxella collected from across Canada in 1997-1998. J Antimicrob Chemother 2000;45:655-62.
20. Hutchinson JM, Jelinski S, Hefferton D, Desaulniers G, Parfney PS. Role of diagnostic labeling in antibiotic prescription. Can Fam Physician 2001;47:1217-24.
21. McIsaac WJ, Goel V. Sore throat management practices of Canadian family physicians. Fam Pract 1997;14:34-9.
22. Arnold SR, Allen UD, Al-Zahrani M, Tan DH, Wang EE. Antibiotic prescribing by pediatricians for respiratory tract infection in children. Clin Infect Dis 1999;29:312-7.
23. Paluck E, Katzenstein D, Frankish CJ, Herbert CP, Milner R,Speert D, et al. Prescribing practices and attitudes toward giving children antibiotics.Can Fam Physician 2001;47: 521-7.
24. Wang EE, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian pre-school children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis 1999;29:155-60.
25. Pennie RA. Prospective study of antibiotic prescribing for children. Can Fam Physician 1998;44:1850-6.
26. Lewis J. NaReS: your national research system. Can Fam Physician 1989;35:837-9.
27. McIsaac WJ, Goel V, To T, Permaul JA, Low DE. Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. J Fam Pract 2002;51:339-44.
28. Stata Corporation. Stata statistical release 0.6. College Station, Tex:Stata Corporation: 1999.
29. College of Family Physicians of Canada. 2001 CFPC National Family Physician Workforce Survey. Part of the Janus project: Family physicians meeting the needs of tomorrow's society. Mississauga, Ont: College of Family Physicians of Canada: 2001.
30. Hueston WJ, Mainous AG, Dacus EN, Hopper JE. Does acute bronchitis really exist? A reconceptualization of acute viral respiratory infections. J Fam Pract 2000;49:401-6.
31. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM. Hoffstein V, et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998;114(Suppl):133-81S.
32. Gonzales R, Steiner F, Lum A, Barrett PH. Decreasing antibiotic use in ambulatory practice. Impact of a multidimensional intervention on the treatment of uncompleted acute bronchitis in adults. JAMA 1999;281:1512-9.
33. Miller E, Mackeigan LD, Rosser W, Marshmann J. Effects of perceived patients demad on prescribing anti-infective drugs. CMAJ 1999;161:139-42.
34. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis: blinded, randomized controlled trial of patient information leaflet. BMJ 2002;324:91-4.
35. Metlay JP, Kapoor WN, Fine MJ. The rational clinical examination. Does this patients have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 278:1440-5.
36. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococei in schoolchildren in Pittsburgh. N Engl J Med 2002;346:1200-6.
37. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Houvinen P. Outpatient were erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21:1378-85.
38. McCaig LF, Besser RE, Hughes JM. Trends in antibmicrobial prescribing rates for children and adolescents. JAMA 2002;287:3096-102.